Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transplantation of Autologously Derived Mitochondria for Protection Against Ischemia-reperfusion Injury Following Ischemia in Subjects on ECMO Support

NCT02851758 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.

NCT NCT02851758
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02851758 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transplantation of Autologously Derived Mitochondria for Protection Against Ischemia-reperfusion Injury Following Ischemia in Subjects on ECMO Support
Lead sponsor
Boston Children's Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
August 2, 2017
Completion date
June 30, 2027
Enrollment
16 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

extracorporeal membrane oxygenation complication